http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109574936-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2018-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109574936-B |
| titleOfInvention | Hydroxamic acid compound with HDAC6 inhibitory activity and application thereof |
| abstract | The invention belongs to the technical field of medicines, and relates to a hydroxamic acid compound with HDAC6 inhibitory activity and antitumor activity, in particular to a hydroxamic acid compound containing a parent nucleus of benzindazoles and a parent nucleus of pyrazoloandazoles, pharmaceutically acceptable salts and hydrates thereof, a pharmaceutical composition taking the compound as an active ingredient, and application of the hydroxamic acid compound in preparing a histone deacetylase inhibitor and preparing a medicament for treating and/or preventing cancers. The structure of the compound is shown in formula I or II, wherein X, R, A is described in claims and specification. |
| priorityDate | 2018-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.